Please assess the completion status of the following clinical trial:

Trial Title: An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 21 years of age~  * Life expectancy \> 6 months~ * HF, NYHA class II-IV~ * \> 1 HF related admissions in the last 12 months~ * Fluid congestion (2 signs of pitting oedema, jugular distention, BW elevation, nocturnal dyspnoea score, respiration rate, pulmonary congestion and/or pleural effusion per chest x-ray, ascites)~ * Failure to achieve effective diuresis and congestion relief despite appropriate or escalating diuretic doses or combination of diuretics (eg. Furosemide and Metolazone)~ * Eligible for general anaesthesia and laparoscopic procedure~ * Able to give written informed consent~ * Ability to comply with study procedures and ability to operate the device~ * Women of childbearing potential should use adequate contraception for as long as the device is implanted.~Exclusion Criteria:~* • Any non-cardiac disease with life expectancy \< 1 year~  * Any patient listed for solid organ transplantation~ * Patients with history, or with indication for, mechanical circulatory support~ * iv inotropes required in last 3 months (INTERMACS Score ≤3)~ * Immunocompromised (e.g. chronic steroid treatment, HIV, etc.)~ * Insulin dependent diabetes~ * Severe hyponatraemia as defined by a serum Sodium \< 120 mmol/l~ * Serum Albumin \< 2.5 g/dL~ * eGFR \< 25 ml/min/1.73m2 by MDRD method~ * Previous significant intraabdominal surgery, severe abdominal adhesions, intra-abdominal foreign body (except for small inguinal mesh)~ * Large diaphragmatic hernia, or surgically irreparable, complex or recurring hernia~ * 6 minutes' walk test of less than 100 meter~ * History (\>6 months) of diaphragmatic hernia, inflammatory or ischemic bowel disease and frequent episodes of diverticulitis~ * Gastrointestinal haemorrhage within the last 4 months~ * Bacterial peritonitis episode within the last 24 months~ * \> 2 systemic or local infections, such as urinary tract infection or abdominal skin infection within the last 6 months~ * Liver cirrhosis~ * BMI \> 40 presenting a risk for surgery~ * Patients with contraindications for general anaesthesia or laparoscopic surgery~ * Unsuitability for self-maintenance of the experimental home set-up~ * Presence of any current cancer~ * Presence of any active implantable or body-worn devices that cannot be removed excluding ICD / pacemaker~ * Pregnancy~ * Patients being in another therapeutic clinical study

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Implanted device (Type: EXPERIMENTAL): Implantation and activation of an automated continual water removal system, including 4-months follow up

Based on this trial design, predict the completion outcome and termination type (if applicable).